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Overview of the thesis 
 
Procalcitonin (PCT) and C-Reactive protein are important markers of infection. PCT has been 
shown to be more specific for bacterial infection than CRP. However fully quantitative PCT is 
often only available at academic hospital laboratories particularly in the KwaZulu Natal region. 
Semi-quantitative PCT provides an alternative option to provision of this test that does not 
require further specialized equipment or training.  
This project aims to review the utility of semiquantitative PCT versus CRP in comparison to 
findings on culture in a hospitalized paediatric population, in particular those with suspected 
bacterial meningitis. Although PCT and CRP have been studied extensively with regards to their 
diagnostic and prognostic value, few of these studies have been performed in Africa and no 
known studies have been done looking at the utilisation of semi quantitative PCT in this setting.                                                                                                                  
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Part 1: The Review of Literature 
 
Procalcitonin  
Procalcitonin (PCT) was introduced as a biomarker of sepsis in the early 1990s. [1] PCT is a 116 
amino acid polypeptide precursor of calcitonin, which is synthesized in the thyroid C cells. 
Calcitonin inhibits bone resorption during hypercalcaemic states. [2,3] The cleavage of the three-
part precursor molecule prePCT to the mature calcitonin occurs in the C cells of the thyroid, and 
in other neuroendocrine cells. [4] Other tissue types lack the ability to further cleave immature 
PCT to the mature calcitonin. [4] Procalcitonin constitutes of three sections; the amino terminus, 
immature calcitonin and the carboxyl terminus CCP-1. Pre-PCT is cleaved into PCT which is 
further broken down into mature calcitonin. The production of PCT is under the control of 
calcitonin 1 gene (CALC-1) which is located on chromosome 11.[4]                                                                                                                                                   
PCT is an immunologically active protein which has tightly regulated levels and hence differs 
from other inflammatory molecules such as cytokines, acute phase proteins and leucocyte 
surface markers. It is a good marker of infections secondary to bacterial infections and is 
produced by many tissues such as the liver, kidney and the pancreas in response to inflammation. 
[5,6] 
It is one of the acute phase proteins which rises rapidly in response to inflammation, followed by 
CRP, serum Amyloid A and α1 antichymotrypsin. These proteins also show different rates of 
decrease in the same order. [6] Acute phase reactions to bacterial infections, are more 
pronounced than those seen in viral infections. [6] It has been noted that interferon-ℽ which is 
produced in viral infections, suppresses the production of PCT, enabling the biomarker to 
differentiate between the two types of infection, and to be more specific for bacterial infections. 
[4] 
Local or systemic infection results in PCT production, in response to cytokines such as 
interleukin-6, interleukin-1β and tumour necrosis factor α, which are produced by monocytes. [4] 
The biological effects of PCT include chemokine effects, stimulating release of proinflammatory 
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cytokines and modulating vascular contraction. [5] It has been demonstrated that serum PCT 
levels increase during the course of bacterial, parasitic, or fungal infections, but remain normal 
or slightly increased in viral infections and inflammatory reactions that are not infectious. [7]    
PCT differs from other markers of sepsis such as CRP, lactate and cytokines in that it is more 
specific for sepsis, and can also indicate the severity of sepsis. [3] 
Elevated PCT levels may also be due to non-infectious causes such as chronic kidney disease, in 
paraneoplastic syndromes due to medullary thyroid cancer and use of therapeutic drugs such as 
alemtuzumab and Il-2. These drugs potentiate the release of cytokines. [4] 
Non-thyroidal PCT production was noted in a study by Morgenthaler et al, where 
lipopolysaccharide(LPS) was injected in baboons with absent thyroid glands. A noted response 
of increased PCT levels was noted within 3-5 hours post injection. PCT concentrations of greater 
than 0.2ng/g of wet tissue, were noted in organs such as liver, kidney, the aorta and adrenals. The 
findings of this study illustrated the origin of extra-thyroidal PCT in sepsis.[8] 
A study by Dipalo et al which compared different PCT assays to the BRAMHS PCT Kryptor, 
showed optimum agreement at three diagnostic thresholds for bacterial infections. [9] The 
agreement noted translates into the use of the same PCT cut-offs. [4] In the healthy population, 
the PCT concentration is usually <0.05ug/L, while the concentration is usually higher in the 
newborn period.[4] An increase in PCT is seen in infections, and the increase usually correlates 
with the severity of the infection. [4] Table 1 below describes the commonly used diagnostic 
thresholds for PCT.  
 Table 1 Interpretation of PCT values [4] 
PCT value (ug/L) Interpretation 
<0.05 No infection 
0.05-<0.5 Systemic infection is unlikely although localised infection is possible 
0.5-<2 Systemic infection is possible but other conditions ( for example major 
trauma, recent surgery ) may also induce these values 
2-<10 Systemic infection is likely 
>10 High likelihood of severe bacterial sepsis/septic shock 
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PCT may be used in various clinical settings such as in primary care, casualty and ICU. [4] It is 
used to guide antibiotic treatment in conditions such as acute respiratory tract infections, 
pneumonia and sepsis. [4]  
Studies which looked at PCT guided antibiotic use, showed outcomes of up to 42% reduction in 
antibiotic use as well as a decrease in hospital stay from 7.4 to 5.9 days. [4] This equates to a 
decrease in health related costs. 
Current methods for PCT measurement are immunoassay based.  The first commercially 
available assay was introduced by BRAHMS and this assay has since been adapted by other 
diagnostic companies for the various platforms. Methods used to measure PCT, need to have 
high sensitivity and have detection limits as low as 0.02 ng/ml. [5] The semiquantitative or point 
of care method for PCT (BRAHMS PCT-Q) is based on an immunochromatographic technique 
and is available as a test strip. This is a one-step immunochromatographic assay (sandwich 
principle) using immunogold labelling. Immunochromatography represents a combination of 
chromatography and immunoassay. Briefly, described as an antigen-antibody reaction which 
occurs on a membrane. The antigen is the analyte of interest to be detected. The antibody against 
the antigen of interest is impregnated in a membrane usually made of nitrocellulose along with 
some dyes (immunogold) which produces respective coloured lines according to the presence or 
absence of target analyte.[10] Results are available within minutes, and it does not require any 
specialized expertise or equipment to perform the analysis.  
Semiquantitative PCT (SPCT) methods have been shown to have 93.94% sensitivity and 87.23% 
specificity for severe sepsis. [11] According to a study by Oh et al, these semiquantitative 
methods are fast and effective, and are useful to initiate and guide antibiotic treatment. [12]  
Boo et al reviewed the usefulness of SPCT for the early diagnosis of neonatal sepsis and found 
that a negative SPCT could be reliably used as a rule out for sepsis.[11] In another study looking 
at adult patients with community acquired pneumonia SPCT at admission was found to be an 
excellent test to predict the outcome of pneumonia. The authors reported a receiver operating 
characteristic for mortality prediction area under curve of 0.92. [13]. Another study amongst 
Japanese adult patients determined that the SPCT was as useful for distinguishing bacterial 
infection from other inflammatory diseases in common clinical practice, as the quantitative PCT. 
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[14] The semi quantitative PCT method, may aid in diagnosis of a bacterial infection, yet has 
limited use in monitoring PCT changes over time to review response to treatment.  [12] 
 
Fully quantitative PCT analysis is usually only available in academic centers in the South 
African public health system. Thus the turn-around time for tests referred from other hospitals is 
often much greater than the 1-3 hours required for the result, in order to effectively manage the 
patient.  However, procalcitonin tests costs are significantly higher than those of CRP. Semi 
quantitative methods are cheaper, more readily available and do not require expensive 
instrumentation. 
C-reactive protein vs PCT  
C-reactive protein (CRP) was discovered in 1930 by Tillet and Francis, who noted that the 
protein formed a complex with pneumococcal C-Polysaccharide during pneumonia infections. 
[15] CRP is a sensitive acute-phase reactant for inflammation which is made in the liver, in 
response to interleukin 6. [15,16] It activates the classical complement pathway. [15] 
CRP concentrations increase in response to infection, trauma, surgery and chronic inflammatory 
conditions. Mild inflammatory conditions and viral infections cause lower CRP production than 
bacterial infections, with the highest concentrations being found in severe bacterial infections. 
[15,16] 
CRP methods include immunoturbidimetric and fluorescence labeled ELISA methods, which are 
commonly used. These automated methods offer high sensitivity and specificity. [15] 
Traditional inflammatory markers such erythrocyte sedimentation rate (ESR), white cell count 
and CRP are noted for their poor sensitivity and specificity in bacteremia.[3] Furthermore the 
gold standard diagnostic test which is microbiology culture has limitations of being time 
consuming, together with false negative or false positive results. [3] 
PCT has shown better sensitivity (88%) and specificity (81%) compared to CRP with a 
sensitivity of 75% and specificity of 67% in the diagnosis of bacterial infection. [16]                       
PCT also has an added advantage of being elevated within 2-4 hours, while CRP rises within 12-
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24 hours post inflammation. PCT with a half-life of 24 hours, returns to normal levels far earlier 
than CRP, which may remain high for up to 7 days post recovery. Nargis et al demonstrated that 
the use of PCT reduces the number of days for which antibiotics are taken, and results in a 
reduced hospital admission. [3] 
A study by Hoeber et al noted that changes in PCT and CRP were better predictors of the 
evolution of nosocomial infections, when compared to changes in the white cell count. [17] The 
authors noted CRP as useful in predicting localized bacterial infections, while PCT has been 
useful in the prediction of bloodborne bacterial infections, along with their clinical sequelae.[17] 
The indiscriminate increase in CRP due to viral or bacterial infections, makes PCT a superior 
biomarker in order to differentiate viral from bacterial meningitis.[18] Another advantage of 
measuring PCT instead of CRP, is that use of anti-inflammatory drugs, steroids and 
inflammatory conditions such as inflammatory bowel disease, cannot affect its concentration. 
The study by Vikse et al mentioned that the limitations of PCT in the diagnosis of bacterial 
meningitis in adults, included its decreased concentration when antibiotics are used, and an 
increase in other bacterial infections such as pneumonia and sepsis. [18] Nargis et al noted PCT 
to be a better marker of accuracy than CRP in identifying and in assessing the severity of sepsis. 
The authors noted that PCT testing can lead to earlier disease diagnosis and along with its use for 
monitoring, can thus reduce the unnecessary use of antibiotics. [3] A study by Alkholi et al 
showed that PCT levels were significantly higher in patients with bacterial meningitis (mean, 
24.8 ng/ml) compared to patients with viral meningitis (mean, 0.3 ng/ml) (P<0.001). The study 
also demonstrated that PCT levels in bacterial meningitis group decreased sooner in those 
children after treatment initiation.[7]                                      
Like the studies described above, many of the studies reviewing performance of PCT and CRP 
have used fully quantitative PCT analysis.  One study by Boo et al examining utility in neonatal 
sepsis found that whilst negative SPCT was a good “rule-out” test, and a raised CRP performed 
better as a “rule-in” test for the possibility of sepsis. [10] In another study the areas under the 
resulting curves for SPCT (0.764) were significantly larger than those seen for C-reactive protein 
(0.650, p= 0.02) and white blood cells (0.618, p= 0.006) for the detection of bacterial infection. 
In an ICU setting SPCT was shown to be more specific and sensitive than CRP for the diagnosis 
of sepsis in critically ill patients. [19]  
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The diagnosis of bacterial infections is important, as they are a significant cause of morbidity and 
mortality. [16] The worldwide annual incidence is 1.2 million cases/year, with a 135 000 
deaths.[18] In the South African paediatric population the yearly incidence of bacterial 
meningitis is 40 per 100 000 in the <1 year age group, and 7 per 100 000 in the 1-4 year age 
group [20] In children it is often difficult to determine whether  the aetiology  of  meningitis is  
viral or bacterial. Early diagnosis of bacterial meningitis is critical in order to initiate appropriate 
therapy, and to prevent the unnecessary and widespread use of antibiotics in cases of viral 
meningitis [4,21] 
Distinguishing bacterial and viral meningitis early could also help to reduce hospital admissions.  
Use of clinical criteria, Gram staining, and bacterial antigen testing of CSF as well as the 
inflammatory markers in the blood (CRP level, white blood cell count [WBC], and neutrophil 
count) or CSF (protein level, glucose level, WBC count, and neutrophil count) used alone do not 
offer 100% sensitivity with high specificity for distinguishing bacterial from viral meningitis.  
Results of CSF culture may take a number of days and detection of viral agents using PCR is not 
readily available in most centers. [7] 
The diagnostic challenge posed by similar clinical features of bacterial and viral infections 
makes the role of biomarkers such as PCT critical in identifying bacterial infections. [7] In young 
children the clinical features of meningitis may differ according to age, and are often not the 
classical signs of meningitis found in older children and adults. This poses a diagnostic 
challenge, and makes the role of tests such as CSF chemistry and bacterial culture, blood culture 
and serum PCT or CRP and peripheral white cell count imperative in making the diagnosis. [20] 
The bacterial meningitis score (BMS) is useful in differentiating bacterial from viral meningitis. 
The score is negative when the following are absent; CSF gram stain, CSF neutrophil count ≥ 
1000 cells/mm3. CSF protein ≥0.8 g/l, peripheral blood absolute neutrophil count ≥ 10 000 
cell/mm3 and history of seizures peri-onset of presentation. [3] According to Boyles et al, when 
the BMS is negative, the negative predictive value is 99.9%. The limitation for the score is that it 
is not validated to use in certain patient groups; such as infants of less than 2months of age and 
in immunocompromised patients amongst others. [18]      
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CRP testing is readily available in most labs in South Africa, whilst PCT is limited to the large 
urban centers and academic laboratories. The use of semi-quantitative, point of care PCT 
analysis using immunochromatography technology allows for this testing to be accessible to all 
patients in less well-resourced health care facilities. There is however the limitation of prior 
centrifugation of the patient sample, which makes the test impractical in rural point of care 
settings. 
There are very few studies performed in an African population reviewing the utility of PCT and 
the authors could not find any studies in this population that examined the utility of semi-
quantitative PCT measurements.[22, 23. 24] 
 
The aims of this study were to a) describe the utilisation of semiquantitative serum PCT levels in 
the diagnosis of bacterial infections in a South African paediatric population and b) to compare its 
utility in a subset of patients to aid in diagnosis of bacterial meningitis  
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Abstract: 
Background: 
The high mortality and morbidity due to bacterial infections such as meningitis, alongside the 
long turnaround times for gold standard microscopy and culture testing, warrants alternative 
laboratory tests such as C-reactive protein (CRP) and procalcitonin(PCT), which demonstrate 
adequate test sensitivity and specificity. In addition, there is a  need for more studies a in Africa, 
which will show the diagnostic value of CRP and PCT in bacterial infections. The aims of this 
study were a) to describe the utilisation of semiquantitative serum PCT in aiding with the 
diagnosis of bacterial infections in a South African paediatric population and b) to compare the 
utility of PCT in a subset of patients with suspected bacterial meningitis. 
Methods 
A retrospective observational study with charts review was done. It included data for all 
paediatric patients admitted to the King Edward Hospital (Durban, South Africa) for which semi 
quantitative PCT testing was performed for the period April 2013- April 2016. Descriptive 
statistical methods were employed for the analysis of data. 
Results  
The semi-quantitative PCT results correlated well with the serum CRP levels and showed 
significant correlation with extent of rise in CRP.  A statistically significant (p=0.035) difference 
of median CRP levels across different categories of PCT levels, with higher values associated 
with PCT categories associated with greater degrees of infection. Kappa statistic analysis 
performed to determine agreement between positive and negative culture results with positive 
and negative semi quantitative PCT results, showed poor observed agreement of 53.13% 
(acceptable >75%). 
Conclusions 
Findings of the current study do not demonstrate added benefit of use of semi-quantitative PCT 
over traditional CRP. Further studies will need to be done to examine utility of the 
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semiquantitative PCT test for early diagnosis specific bacterial infections including meningitis 
and pneumonia in this specific population. 
Background: 
Procalcitonin (PCT) was introduced as a biomarker for sepsis as early as 1993. [1]  PCT  is a 116 
amino acid polypeptide precursor of calcitonin, which is synthesized in the thyroid C cells. [2,3]                                                                                                                                                    
PCT is an immunologically active protein which has tightly regulated levels and hence differs 
from other inflammatory molecules such as cytokines, acute phase proteins and leucocyte 
surface markers. [4] 
Local or systemic infection results in PCT production in response to monocytes. The biological 
effects of PCT include chemokine effects, stimulating release of pro-inflammatory cytokines and 
modulating vascular contraction. [4] It has been demonstrated that serum PCT levels increase 
during the course of bacterial, parasitic, or fungal infections, but remain normal or slightly 
increased in viral infections and inflammatory reactions that are not infectious. [5] PCT differs 
from other markers of sepsis such as CRP, lactate and cytokines in that it is more specific for 
sepsis and can also indicate the severity of sepsis. [1] 
PCT measurements are performed on immunoassay based methods. They are quantitative or 
semi-quantitative, and are measured in serum or plasma. Methods used to measure PCT need to 
have high sensitivity and have detection limits as low as 0.02 ng/ml. [4] Semi-quantitative PCT 
methods have been shown to have 93.94% sensitivity and 87.23% specificity for severe sepsis. [6] 
According to a study by Oh J et al, these semi-quantitative methods are fast and effective, and 
are useful to guide antibiotic treatment. [6]. Fully quantitative PCT analysis performed on an 
immunoassay analyser is usually only found in the larger academic and tertiary regional hospital 
laboratories.  However, quantitative procalcitonin tests costs are significantly higher than those 
of CRP. Semi-quantitative methods are cheaper, more readily available and do not require 
expensive instrumentation.[7]          
C- reactive protein (CRP) is a sensitive acute-phase reactant for inflammation which is made in 
the liver. It activates the classical complement pathway. [7] CRP concentrations increase in 
response to infection, trauma, surgery and chronic inflammatory conditions. Mild inflammatory 
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conditions and viral infections cause lower CRP production than bacterial infections, with the 
highest concentrations being found in severe bacterial infections. [7] CRP methods include 
immunochemical techniques such as immuno -turbidimetric and immuno-nepholometry both of 
which are commonly used. Traditional inflammatory markers such erythrocyte sedimentation 
rate (ESR), white cell count and CRP are noted for their poor sensitivity and specificity in 
bacteraemia.[3] Furthermore the gold standard diagnostic test which is microbiology culture has 
limitations of being time consuming, together with false negative or false positive results. [3] 
PCT has shown better sensitivity (88%) and specificity (81%) compared to CRP with a 
sensitivity of 75% and specificity of 67% in the diagnosis of bacterial infection. [8]                       
PCT also has an added advantage of being elevated within 2-4 hours, while CRP rises within 12-
24 hours post inflammation. PCT with a half-life of 24 hours, returns to normal levels far earlier 
than CRP, which may remain high for up to 7 days post recovery. Nargis et al demonstrated that 
the use of PCT reduces the number of days for which antibiotics are taken, and results in a 
reduced hospital admission. [3] A study by Hoeber et al noted that changes in PCT and CRP were 
better predictors of the evolution of nosocomial infections, when compared to changes in the 
white cell count. [9] The authors noted CRP as useful in predicting localized bacterial infections, 
while PCT has been useful in the prediction of blood-borne bacterial infections, along with their 
clinical sequelae.[9] 
The indiscriminate increase in CRP due to viral or bacterial infections, makes PCT a superior 
biomarker in order to differentiate viral from bacterial meningitis.[10] Another advantage of 
measuring PCT instead of CRP, is that use of anti-inflammatory drugs, steroids and 
inflammatory conditions such as inflammatory bowel disease, cannot affect its concentration. 
Vikse et al stated that one of the limitations of PCT in the diagnosis of bacterial meningitis in 
adults, included its decreased concentration when antibiotics are used, and an increase in other 
bacterial infections such as pneumonia and sepsis. [10] Nargis et al noted PCT to be a better 
marker of accuracy than CRP in identifying and in assessing the severity of sepsis. The authors 
noted that PCT testing can lead to earlier disease diagnosis and along with its use for monitoring, 
can thus reduce the unnecessary use of antibiotics. [3] 
One study by Boo et al examining utility in neonatal sepsis found that whilst negative SPCT was 
a good “rule-out” test, a raised CRP performed better as a “rule-in” test for the possibility of 
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sepsis. [11] In another study the areas under the resulting curves for SPCT (0.764) were 
significantly larger than those seen for C-reactive protein (0.650, p= 0.02) and white blood cells 
(0.618, p= 0.006) for the detection of bacterial infection. In an ICU setting SPCT was shown to 
be more specific and sensitive than CRP for the diagnosis of sepsis in critically ill patients. [12] 
                                   
CRP testing is readily available in most labs in South Africa, whilst PCT is limited. The use of 
semi-quantitative point of care PCT analysis using immuno-chromatography technology allows 
for this testing to be accessible to all patients in less well-resourced health care facilities. 
The diagnosis of bacterial infections is important, as it confers a significant cause of morbidity 
and mortality. [8] The worldwide annual incidence is 1.2 million cases/year, with a 135 000 
deaths.[10] In the South African paediatric population the yearly incidence of bacterial meningitis 
is 40 per 100 000 in the <1 year age group, and 7 per 100 000 in the 1-4 year age group[13] In 
children it is often difficult to determine if  the aetiology  of  meningitis is  viral or bacterial. 
Early diagnosis of bacterial meningitis is critical in order to initiate appropriate therapy and to 
prevent the unnecessary and widespread use of antibiotics in cases of viral meningitis [8,14] 
Distinguishing between bacterial and viral meningitis early could also help to reduce hospital 
admissions.  A study by Alkholi et al showed that PCT levels were significantly higher in 
patients with bacterial meningitis (mean, 24.8 ng/ml) compared to patients with viral meningitis 
(mean, 0.3 ng/ml) (P<0.001). The study also demonstrated that PCT levels in bacterial 
meningitis group decreased sooner in those children after treatment initiation. Use of clinical 
criteria, Gram staining, and bacterial antigen testing of CSF as well as the inflammatory markers 
in the blood (CRP level, white blood cell count [WBC], and neutrophil count) or CSF (protein 
level, glucose level, WBC count, and neutrophil count) used alone do not offer 100% sensitivity 
with high specificity for distinguishing bacterial and viral meningitis.  Results of CSF culture 
may take a number of days and detection of viral agents using PCR is not readily available in 
most centers. [5] 
The diagnostic challenge posed by similar clinical features of bacterial and viral infections 
makes the role of biomarkers such as PCT critical in identifying bacterial infections. [5] In young 
children the clinical features of meningitis may differ according to age and are often not the 
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classical signs of meningitis found in older children and adults. This poses a diagnostic challenge 
and makes the role of tests such as CSF chemistry and bacterial culture, blood culture and serum 
PCT or CRP and peripheral white cell count imperative in making the diagnosis. [13] The 
bacterial meningitis score (BMS) is useful in differentiating bacterial from viral meningitis. The 
score is negative when the following are absent; CSF gram stain, CSF neutrophil count ≥ 1000 
cells/mm3 , CSF protein ≥0.8 g/l, peripheral blood absolute neutrophil count ≥ 10 000 cell/mm3 
and history of seizures peri-onset of presentation. [1]. According to Boyles et al, when the BMS is 
negative, the negative predictive value is 99.9%. [13] The limitation for the score is that it is not 
validated to use in certain patient groups; such as infants < 2months and immunocompromised 
patients amongst others. [13]                                                     
There are few studies that have investigated the diagnostic value of semi-quantitative PCT in 
detection of bacterial infection in Africa and data available with regards to the clinical utility of 
semi-quantitative PCT for diagnosis of bacterial meningitis is also limited.  
 
The aims of this study were to a) describe the utilisation of semi-quantitative serum PCT in the 
diagnosis of bacterial infections in a South African paediatric population and b) to review its utility 
in a subset of patients to aid in diagnosis of bacterial meningitis  
 
Methods 
Semi-quantitative PCT results for all paediatric patients admitted to the King Edward Hospital 
(Durban, South Africa) performed for the period April 2013- April 2016, were extracted from the 
National Health Laboratory Service (NHLS) laboratory information system central data 
warehouse (CDW). Demographic data, clinical history (where provided) as well as results for 
CRP, white cell count, blood culture, CSF chemistry, microbiology and culture studies were also 
extracted. Sputum culture was not reviewed as part of the study due to the general difficulty with 
obtaining samples from paediatric patients and high prevalence of pulmonary tuberculosis 
endemic in the region. Patient chart review was also performed to obtain additional clinical 
information regarding clinical presentation and management. 
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Semi-quantitative PCT analysis was performed at the King Edward Hospital National Health 
Laboratory Service (NHLS) chemical pathology laboratory. The Brahms PCT-Q assay (Thermo 
Scientific) was used. This method is based on a one-step immuno-chromatographic assay 
(sandwich principle) using immuno-gold labelling. The test procedure is carried out on non-
hemolyzed blood samples that have been centrifuged.  200 μL of serum is pipetted into the round 
cavity of the test trip. The tracer binds to any PCT in the sample and a marked antigen-antibody 
complex is formed. This complex moves by means of capillary action through the test system, 
and in the process, passes through an area containing the test band. Here, the marked antigen-
antibody complex binds to the fixed anti-calcitonin antibodies and forms a sandwich complex. 
This sandwich complex can be seen as a reddish band. The color intensity of the band is 
indicative of the level of PCT.   Results are categorised into four different grades (Grade 0:< 0.5; 
Grade1: 0.5 to < 2.0, Grade2: 2.0 to < 10.0, or Grade 3:  ≥ 10.0 ng/mL). 
CRP was measured using an immuno-turbidimetric based assay on the Beckman Coulter 
DXC800 analyser. 
Suspected meningitis cases were identified based on the documented symptoms and assessment 
by the attending clinicians as per chart review and laboratory requests for CSF biochemistry and 
microscopy (with or without CSF culture) 
The following variables were retrieved from review of patient charts 1) presence of coexisting 
illness; 2) clinical data with regards to signs and symptoms present 3) treatment details 
specifically with regards to initiation of antibiotic treatment during the admission 4) differential 
diagnosis 5) where possible clinical outcomes 
Patients were identified with a unique hospital number on the extracted database. With regards to 
repeat testing only the initial CRP and PCT values were utilized for analysis in this study.  
Inclusion criteria: 
All paediatric patients between 0 months and 12 years admitted   during the period from 1 
April 2013 – 1 April 2016 that had both semi quantitative procalcitonin and CRP testing 
performed within 24 hours of each other. 
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Exclusion criteria 
- Any patient > 12 years old 
- Patients with no CRP performed within 24 hours of PCT  
- Outpatients  
Statistical analysis: Data was analysed using Medcalc statistical software program version 18.11 
(Medcalc, Belgium). Differences between groups in categorical variables were tested for 
significance with the Kruskal Wallis test. Differences in frequencies of findings between groups 
were analyzed by Fischer's exact test. The chi-square test of association was used to assess any 
associations between categorical variables. Kappa statistics was used to compare the level of 
agreement between tests. A p value <0.05 was considered as statistically significant. Ethical 
approval for the study was obtained from the University of KwaZulu Natal Bioethics and 
Research Committee (BREC) (approval number BE404/16) 
 
Results 
During the period of review, a total of 1281 semi-quantitative PCT tests were performed for the 
paediatric population ≤ 12 years of age. A total of 49 patients were identified as fulfilling the 
inclusion criteria following review of extracted data. Results from 49 patients are presented. 
Demographic data and patient summary characteristics are presented in Table 1 below. 
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Table 1 Patient summary characteristics 
 Male  Female Total  
Number 30 19 49 
Age (months)  
(Median range)  
 
0.36 (0.03- 132.07) 
 
1,23 (0.03-118.9) 
 
0.7 (0.03- 132.07) 
PCT  (ng/mL): 
Grade 0(<0.5 ng/mL) 
 
13 
 
8 
 
21 
Grade 1(>0.5<2 ng/mL) 
Grade 2 (>2<10 ng/mL) 
8 
0 
5 
2 
13 
2 
Grade 3 (>10 ng/mL) 7 4 11 
CRP mg/L 
(Median range)  
 
31 (0-323) 
 
28 (6-320) 
 
28 (0-323) 
White cell count ( x 109 cells/L) 
Mean (SD)  
 
14.4 (7.9) 
 
12.2 (6) 
 
13.2 (7)  
  
 
Patient clinical information: 
The majority of patients, 65% (n=32) were neonates from the nursery ward or neonatal high 
care. The remainder of patients were from the paediatric resuscitation unit (18%; n=9) and 
general medical paediatric wards (14%; n=7) with 1 patient from intensive care unit.  
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Seven children presented with features suggestive of possible meningitis which included bulging 
fontanelle, fisting and meningism. Fever was described in clinical notes for less <5% of patients 
CSF culture was performed on 42% (n=20) of patients with positive results in 4 individuals. 
Blood culture was performed on 47% (n=22), with positive results in more than sixty percent 
(n=14) patients. Organisms identified on positive culture results are summarized in Table 2 
below  
 
Table 2 Organisms identified in culture  
 Organisms identified  
CSF Culture  Staphylococcus aureus 
 Cryptococcus neoformans 
 Klebsiella pneumoniae 
 Actinobacteria baumanni 
Blood Culture   Staphylococcus aureus 
 Staphylococcus epidermis 
 
Correlation of semi-quantitative PCT with CRP and other markers: 
Kruskal Wallis analysis was used to the describe the relationship between the categorical 
variable of semi-quantitative PCT results with continuous variable of serum CRP results. 
Analysis revealed a statistically significant (p=0.035) difference of median CRP levels across 
different categories of PCT levels, with higher values associated with PCT categories associated 
with greater degrees of bacterial infection i.e. category 3 (PCT>2 ng/mL) and category 4 
(PCT>10 ng/mL)  
XXVI 
 
Kruskal Wallis analysis between absolute white cell counts and semi-quantitative PCT results 
showed no significant trend between categories of PCT results and WCC values (p=0.7) 
Analysis between serum CRP levels and WCC showed no correlation between the two set of 
data with Spearman correlation of 0.017 
 
Semi-quantitative PCT and culture results:  
For analysis CSF and blood culture were combined. Table 3 depicts the paired results for culture 
and PCT categorization.  Kappa statistical analysis was performed to determine agreement 
between positive and negative culture results with positive (categories 1,2 and 3) and negative 
(category 0) semi-quantitative PCT results. Kappa statistic indicated poor observed agreement of 
53.13% (acceptable would be considered >75%) 
Table 3 Paired results for culture and PCT categorization 
 
 PCT Categorization  
 Category 0 1 2 3 
Culture Positive  10 4 2 2 
Culture Negative   7 5 1 1 
Notes :PCT categorization 0=<0.5 ng/mL; 1=>0.5≤2 ng/mL; 2=>2 ≤10 ng/mL;3=>10 ng/mL) 
 
In order to further analyse relationship between the semi-quantitative PCT results, CRP values 
and culture results. CRP was categorised into two groups Group 1 < 50 mg/L and Group 2 ≥50 
mg/L. The value of 50 mg/L was chosen in view of previous reports, indicating this was the best 
cut off for the diagnosis of sepsis (sensitivity 98.5% and specificity 75%) [15] 
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Table 4. Paired results of CRP categoristion with culture results and semi-quantitative 
PCT categorization 
 CRP  Categorisation  
  Group 1 ( < 50 mg/L)   Group 2 ( ≥50 mg/L ) 
Culture Positive  11 9 
Culture Negative   9 6 
 
 Semiquantative PCT (SPCT) Categorisation     
PCT Category 0 1 2 3 
Group 2 CRP ( ≥50 mg/L) 5 4 2 7 
Notes:Semi-quantitative PCT= SPCT  
PCT categorization 0=<0.5 ng/mL; 1=>0.5≤2 ng/mL; 2=>2 ≤10 ng/mL;3=>10 ng/mL) 
Kappa statistical analysis was performed to determine agreement between positive and negative 
culture results with categories CRP group 1 and 2. Kappa statistic also showed poor observed 
agreement of 51.43% 
Review of the suspected meningitis group: 
With regards to patients with suspected CSF infection as defined by testing request for CSF 
chemistry, microscopy and culture and clinical chart review a total of 18 patients were identified. 
The characteristics of these patients are summarized in Appendix1 of the paper. Of these 18 
patients, 9 were male, and 9 were female. Age range was from 0.03 months to 118.9 months 
(median = 0.685 months). 
Patients with clinical features suggestive of meningitis were n=5(27.8%), while those with 
positive culture results were n=4 (22.2%). Symptomatic patients from those who were culture 
positive were n=1(25%). 
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Patients with high CSF protein results were n=9(50%), while n=2(22.2%) of those with high 
CSF protein results, also had positive CSF culture results. CSF microscopy findings showed that 
n=1(25%) of total CSF culture positive results showed predominantly polymorphonuclear cells, 
n=1(25%) showed no cells, n=1(25%) had no microscopy done, and n=1(25%) had a few 
lymphocytes. (see supplemental data for Table summarizing this data for all patients)  
On chart review it was noted that most of this group where placed on multiple antibiotic agents 
irrespective of culture findings. 
Discussion  
This is the first study to the authors knowledge to describe the utility of semi-quantitative PCT 
testing in an African paediatric population. This assay would be perfectly suited for a resource 
constrained environment as it requires no special equipment or technical expertise to perform 
and is less costly than the formal assay.  It is used primarily for sepsis diagnosis but not for 
monitoring therapeutic follow-up. This is evidenced in our study findings, where serial 
measurements were done for less than 25% of the patients reviewed, with only n= 11 having 
more than one result during the admission period. 
As would be expected the semi-quantitative PCT results correlated well with the serum CRP 
levels and showed significant correlation with extent of rise in CRP. However no correlation was 
seen with white cell count, which has been shown in previous studies to be less useful than CRP 
for detection of bacterial infection. [16] Concordance of the semi-quantitative PCT results with the 
gold standard of culture was poor. This could be due to the following reasons: the small number 
of available culture results, the presence of possible contamination of culture specimen ; the 
small number of study cohort as well as the small number of patients with semi-quantitative PCT 
results in  category 2 and above (n=6) (which is more suggestive of bacterial infection than 
category 1). Both CRP and semi-quantitative PCT agreement with culture results demonstrated a 
kappa statistic of less than the minimum acceptable of 75% (with CRP slightly worse at 51% 
versus PCT kappa statistic value of 53%)  
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One of the major limitations of the study was the small sample size, in particularly for the subset 
group with suspected meningitis. This resulted in difficulty drawing any definitive conclusions 
from the data extracted including not being able to define cutoffs for semiquantitative PCT that 
would be indicative of bacterial meningitis. Additionally, possible contamination of blood 
culture specimens for approximately nine of the samples further reduced numbers for examining 
sensitivity and specificity of the semi-quantitative PCT against the gold standard of culture. It 
was also noted that of those patients with positive CSF culture results, only 25% were 
symptomatic. This is supportive of studies that have found that clinical signs of meningism are 
not reliable in the paediatric group, and a high index of suspicion is needed.  [17] 
Confounders such as possible CSF and blood culture contamination and antibiotic use possibly 
affected culture results. Previous studies have shown that antibiotic use can affect confirmatory 
culture testing. [17] 
Another limitation was the lack of compete medical records for some of the patients and lack of 
further investigations such as viral serology for exclusion of a viral meningitis.  Due to the 
retrospective nature of this study semi-quantitative PCT analysis was not paired with formal PCT 
values to assess this correlation. However previous studies (including in house study performed, 
data not published) have confirmed good correlation with semi-quantitative and formal PCT 
assessment. [18]  
 
Conclusion:  
The finding of the current study does not demonstrate added benefit of use of semi-quantitative 
PCT over traditional CRP. Further studies in larger cohorts will need to be done to examine 
utility of the semi-quantitative PCT test for early diagnosis of specific bacterial infections 
including meningitis and pneumonia in this specific population. 
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Manuscript Appendices: 
Appendix 1: The characteristics of patients with suspected bacterial meningitis  
Patient  Age ( 
months) 
Gender Clinical 
symptoms 
PCT CRP CSF 
Total 
protein 
CSF 
glucose  
CSF 
Microscopy  
CSF  
Culture 
Antibiotics used 
1 3.5  F No history <0.5 28 0.62 3.2 10poly, 4 
lymphocyte 
Positive S. 
aureus 
Not documented 
 2 3.8 M Bulging 
fontanelle 
;increased 
tone 
<0.5 8 1.57 2.6 1 neutroph, 1 
lymph 
Negative Augmentin,gentamicin, 
erythromycin, 
imipenen 
3 3.8 M Bulging 
fontanelle 
,increased 
tone 
<0.5 15 0.13 3.2 No cells Negative Augmentin, 
gentamycin, 
erythromycin 
4 14.6 M Meningism 
present  
<0.5 152 ND ND ND Positive 
Cryptococcus 
Bactrim, cloxacillin, 
Bactrim,PZA, 
rifampicin, ISZ, 
ethambutol 
5 23,5 M No history >0.5 89 0.14 3.4 2poly Negative Tazocin, ciprobay, 
flucloxacillin, 
imipenem 
6 118.9 F No  history  >10 320 0.27 2.7 No cells Negative Not documented 
7 0.07 F No 
Meningism 
>10 12 1.81 4.9 8poly,32lymph, 
>1000 
eythrocytes 
Negative Gentamycin, solpen, 
tazocin, amikacin, 
imipenem 
8 0.33 M No 
Meningism  
>10 58 0.79 6.4 0poly, 2lymph Negative Gentamicin, solpen 
9 0.8 M No 
Meningism 
<0.5 25 ND ND Scanty poly 
and lymph 
Negative Amikacin, tazocin 
ciproflox, fluconazole, 
gentamicin, solpen 
10 0.4 F No 
Meningism 
>10 28 1.88 4.5 ND Negative Gentamicin, ampicillin, 
vancomycin, imipenem 
11 0.17 F No  history <0.5 7 0.92 2.7 0 neutrophils, 
0 lymphs 
Positive 
Klebsiella 
pneumonia 
Not documented 
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Table 
continued 
Patient  
Age ( 
months) 
Gender Clinical 
symptoms 
PCT CRP CSF 
Total 
protein 
CSF 
glucose  
CSF 
Microscopy  
CSF  
Culture 
Antibiotics used 
 
12 
 
0.7 
 
F 
Jittery <0.5 165 0.59 6.5 0 poly, 0 lymph Negative Solpen, imipenem, 
vancomycin, tazocin 
13 0.9 M No 
Meningism  
<0.5 14 0.83 5.8 0 cells Negative Imipenem, 
clarithromycin, 
tazocin, amikacin, 
ampicillin, flagyl 
14 0.3 M No history  >0.5 130 2.42 8.5 0 poly, 2lymph, 
70 
erythrocytes 
Positive 
Acinebacter 
Not documented 
15 0.3 M No history  >10 72 0.59 4.4 0 cells Negative Not documented 
16 0.03 F Decreased 
tone  
>0.5 6 1.14 10 Scanty 
leucocytes 
Negative Solpen, gentamicin, 
amikacin 
17 1.5 F No history  >2 160 1.5 5 0 cells Negative Not documented 
18 0.5 F No 
Meningism 
>0.5 7 1.48 1.6 ND Negative Amikacin, ciprobay, 
gentamicin 
 
 
 
 
 
 
 
 
 
 
 
 
XXXIV 
 
Appendix 1: The final Study Protocol (Include the final protocol which was given 
full approval by Brec and/or the postgrad office) 
MMED Research Protocol 
Title: Comparison of Semi quantitative Procalcitonin 
versus C-Reactive Protein for the diagnosis of bacterial 
meningitis in children  
 
 
 
 
 
Dr Unathi Ngxamngxa 
213573224 
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Title of study 
Comparison of  semi quantitative Procalcitonin versus C-Reactive Protein for the diagnosis of 
bacterial meningitis in children  
Aim 
To compare the ability of serum procalcitonin (semi quantitative PCT) versus C-reactive protein 
(CRP), to differentiate between bacterial and viral meningitis in a paediatric population. 
 
Objectives 
a) Determine correlation of semi quantitative PCT versus CRP results to microscopic and culture 
evidence of bacterial meningitis  
b) Determine whether procalcitonin measured alone, or used in conjunction with c-reactive 
protein is a better predictor/marker of bacterial meningitis infection in paediatric patients 
c) Determine possible diagnostic cut off levels for semi quantitative PCT and CRP for bacterial 
meningitis 
d) Determine correlation of PCT and CRP with other inflammatory markers White cell count and 
erythrocyte sedimentation rate (ESR) in the presence of bacterial meningitis. 
 
Summary of proposed study 
The high morbidity and mortality rate due to meningitis in the paediatric population, makes it 
imperative that diagnosis is made promptly so as to initiate the appropriate therapy. PCT and 
CRP are important adjunctive tests to gram staining and culture of CSF and blood samples in 
making the diagnosis.                                                                                                                  
This project aims to compare how these two biomarkers compare when used to differentiate 
between bacterial and viral meningitis. Although PCT and CRP have been studied extensively 
regarding their diagnostic and prognostic value, few of these studies have been performed in 
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Africa and no studies have been done looking at the utilization of semi quantitative PCT in this 
setting.  Both tests are frequently requested by clinicians, and it is important to determine 
whether this practice is both evidence based, and cost effective.                                                 
The study will look at the diagnostic value of semiquantitative PCT and CRP results of 
paediatric patients with meningitis from one of the local hospitals, King Edward Hospital. 
Background and literature review 
The diagnosis of bacterial infections is important, as they are a significant  cause of morbidity 
and mortality.(1) The worldwide annual incidence is 1.2 million cases/year, with a 135 000 
deaths.(2).In the South African paediatric population the yearly incidence of bacterial meningitis 
is 40 per 100 000 in the <1 year age group, and 7 per 100 000 in the 1-4 year age group(3) In 
children it is often difficult to determine if  the aetiology  of  meningitis is  viral or bacterial. 
Early diagnosis of bacterial meningitis is critical in order to initiate appropriate therapy and to 
prevent the unnecessary and widespread use of antibiotics in cases of viral meningitis (1,4) 
Distinguishing bacterial and viral meningitis early could also help to reduce hospital admissions.  
Use of clinical criteria, Gram staining, and bacterial antigen testing of CSF as well as the 
inflammatory markers in the blood (CRP level, white blood cell count [WBC], and neutrophil 
count) or CSF (protein level, glucose level, WBC count, and neutrophil count) used alone do not 
offer 100% sensitivity with high specificity for distinguishing bacterial and viral  meningitis.  
Results of CSF culture may take a number of days and detection of viral agents using PCR is not 
readily available in most centers. (5) 
The diagnostic challenge posed by similar clinical features of bacterial and viral infections 
makes the role of biomarkers such as PCT critical in identifying bacterial infections. (5) 
In young children the clinical features of meningitis may differ according to age, and are often 
not the classical signs of meningitis found in older children and adults. This poses a diagnostic 
challenge, and makes the role of tests such as CSF chemistry and bacterial culture, blood culture 
and serum PCT or CRP and peripheral white cell count imperative in making the diagnosis. (3) 
The bacterial meningitis score is useful in differentiating bacterial from viral meningitis. The 
score is negative when the following are absent; CSF gram stain, CSF neutrophil count ≥ 1000 
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cells/mm3  , CSF protein ≥0.8 g/l, peripheral blood absolute neutrophil count ≥ 10 000 cell/mm3 
and history of seziures peri-onset of presentation. (3). According to Boyles et al, when the BMS is 
negative, the negative predictive value is 99.9%. The limitation for the score is that it is not 
validated to use in certain patient groups; such as infants< 2months and immunocompromised 
patients amongst others. (3)                                                     
Procalcitonin is a 116 amino acid polypeptide which is a precursor of calcitonin, which is 
synthesized in the thyroid C cells. Calcitonin inhibits bone resorption during hypercalcaemic 
states. (6,7)  Procalcitonin became a useful biomarker for sepsis in 1993. (9)                                                                                                                                                    
PCT is an immunologically active protein which has tightly regulated levels and hence differs 
from other inflammatory molecules such as cytokines, acute phase proteins and leucocyte 
surface markers. It is a good marker of infections secondary to bacterial infections and is 
produced by many tissues. (8) 
Local or systemic infection results in PCT production in response to monocytes produced. The 
biological effects of PCT include chemokine effects, stimulating release of proinflammatory 
cytokines and modulating vascular contraction. (8)It was been demonstrated   that serum PCT 
levels increase during the course of bacterial, parasitic, or fungal infections, but remain normal 
or slightly increase in viral infections and inflammatory reactions that are not infectious. (5)    
PCT differs from other markers of sepsis such as CRP, lactate and cytokines in that it is more 
specific for sepsis, and can also indicate the severity of sepsis. (9) 
PCT methods are immunoassay based. They are quantitative or semi-quantitative, and are 
measured in serum or plasma. Methods used to measure PCT need to have high sensitivity and 
have detection limits as low as 0.02 ng/ml. (8  Semiquantitative PCT methods have been shown 
to have 93.94% specificity and 87.23% specificity for severe sepsis. (10)  According to a study by 
Oh J et al, these semiquantitative methods are fast and effective, and are useful to guide 
antibiotic treatment. Both these methods are available in South African laboratories with 
quantitative analysis found in larger academic centres.  However Procalcitonin tests costs are 
significantly higher than that of CRP. Semi quantitative methods are cheaper, more readily 
available and do not require expensive instrumentation. 
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C-reactive protein was discovered in 1930 by Tillet and Francis, who noted that the protein 
formed a complex with pneumococcal C-Polysaccharide during pneumonia infection. (11)          
CRP is a sensitive acute-phase reactant for inflammation which is made in the liver. It activates 
the classical complement pathway. (11) 
CRP concentrations increase in response to infection, trauma, surgery and chronic inflammatory 
conditions. Mild inflammatory conditions and viral infections cause lower CRP production than 
bacterial infections, with the highest concentrations being found in severe bacterial infections. (11) 
CRP methods include immunoturbidimetric and Fluorescence labeled ELISA methods, which 
are commonly used. These automated methods offer high sensitivity and specificity. Latex 
agglutination methods are used for semiquantitative testing and are available as point of care 
tests(11) 
PCT has shown better sensitivity (88%) and specificity (81%) compared to CRP with a 
sensitivity of 75% and specificity of 67% in the diagnosis of bacterial infection. (1)                       
PCT also has an added advantage of being elevated within 2-4 hours, while CRP rises within 12-
24 hours post inflammation. PCT with a half-life of 24 hours, returns to normal levels far earlier 
than CRP, which may remain high for up to 7 days post recovery. Nargis et al demonstrated that 
the use of PCT reduces the number of days for which antibiotics are taken, and results in a 
reduced hospital admission. (7) 
The indiscriminate increase in CRP due to viral or bacterial infections, makes PCT a superior 
biomarker in order to differentiate viral from bacterial meningitis. (2) Another advantage of 
measuring PCT instead of CRP, is that use of anti-inflammatory drugs, steroids and 
inflammatory conditions such as inflammatory bowel disease, cannot affect its concentration. 
The study by Vikse et al mentioned that the limitations of PCT in the diagnosis of bacterial 
meningitis in adults, included its decreased concentration when antibiotics are used, and an 
increase in other bacterial infections such as pneumonia and sepsis.  
A study by Alkholi et al showed that PCT levels were significantly higher in patients with 
bacterial meningitis (mean, 24.8 ng/ml) compared to patients with viral meningitis (mean, 0.3 
ng/ml) (P<0.001). The aim of the present study was to determine the role of serum PCT levels in 
the early diagnosis of bacterial meningitis and to document their efficacy in the differential 
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diagnosis of viral and bacterial meningitis. The study also demonstrated that PCT levels in 
bacterial meningitis group decreased sooner in those children after treatment initiation.                                         
Guidelines from Boyles et al recommend that antibiotic treatment may be stopped when CRP is 
<20mg/l, as it has a negative predictive value for bacterial meningitis of 99%, and PCT <0.5 
ng/ml, as it has a negative predictive value of 99% for bacterial meningitis. 
Whilst both PCT and CRP testing are readily available in most labs in South Africa,  there are 
however few studies that have investigated their diagnostic and prognostic value in early 
detection of bacterial meningitis in Africa. 
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Study design 
A retrospective, observational, analytical study  
Study population and location 
Children aged between 4 months and 12 years admitted with meningitis at King Edward 
Hospital. 
 Sampling strategy 
Procalcitonin and CRP results from paediatric wards requested and performed over the period of 
the study April 2013- April 2016 will be extracted from the central data warehouse.                                                                                                        
Purposive sampling will be used. 
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Chart review of identified patients will be performed using patient folders. 
Sample size 
 Based on a previous study, and after consultation with the statistician, a sample size of 40 was 
decided upon. ( refer to study Alkholi et al ). The prevalence of bacterial meningitis was found to 
be 18 cases in the whole of 2015 at the study hospital. Based on this a 3 year study period with a 
sample size of 40 cases was chosen. 
 
Inclusion criteria 
- Paediatric patients between 4 months and 12 years admitted with suspected meningitis  
during the period  from April  2013 – April 2016 that have  had procalcitonin and CRP  
testing performed 
Exclusion criteria 
 Patients with documented  infections in addition to meningitis  
Data collection strategy and methods 
Procalcitonin and CRP results from paediatric wards requested and performed over the period of 
the study will be extracted from our laboratory information system central data warehouse. The 
data collection tool will be the printout of patient details and data from the central data 
wharehouse. 
Chart review of identified patients will be performed using the hospital information system. 
Patients with meningitis will be identified as those diagnosed based on evaluation of history, 
physical examination, CSF laboratory findings, identification of bacterial agents in CSF, Gram 
staining, and cultures. Bacterial meningitis will be defined according to CSF laboratory findings 
(increased protein ≥2 g/l, decreased glucose ratio ≤0.4, and leukocyte count ≥1500 × 10/l and 
polymorph nuclear leukocyte domination), identification of bacterial agents in Gram staining, 
and/or positive bacterial culture. Viral meningitis will be defined as viral if the viral culture, 
serological testing, pleocytosis, or reverse transcriptase polymerase chain reactions were 
positive, and the bacterial culture was negative 
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Statistical analyses 
Data will be entered into SPSS version 24 (Statistical Packages for the Social Sciences) for 
analysis. A p value <0.05 will be considered as statistically significant. A descriptive statistical 
analysis of the data (means, standard deviations, ranges, frequencies and percentages, etc.) will 
initially be conducted prior to inferential analysis.                                               
Differences between groups in continuous variables will be tested for significance with the 
Mann-Whitney test. Differences in frequencies of findings between groups will be analyzed by 
Fischer's exact test. Sensitivity and specificity will be derived from the receiver operating 
characteristic (ROC) curve, and area under the ROC curve. The chi-square test of association 
will be used to assess any associations between categorical variables. Kappa statistics will be 
used to compare the level of agreement between tests. 
Study period 
Results and data from April 2013- April 2016. 
Study Design: Retrospective, observational, cross sectional study 
Limitations of the study: 
 This is a retrospective data review and therefore, lack of data may limit the number of 
data subjects for analysis. 
Ethical considerations: 
There will be no patient interaction as this is a retrospective chart review. The risks are therefore 
minimal. This study will have no impact on patients and will not affect their treatment or 
outcome. It is a non-invasive study and does not require any extra blood sampling. Patient 
confidentiality will be maintained at all times. Data will be collected on a password protected 
computer and the primary investigator will be the only person with access to it. Patients will be 
identified by hospital numbers and their identities will not be revealed.  
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The benefit of the study is that the clinical data acquired from these charts has the potential to 
guide patient testing for infective markers to allow for increased cost effectiveness and 
sensitivity in the diagnosis of bacterial meningitis in children 
 
 
Supervision and collaboration: 
This research project will be performed under the supervision of Dr Verena Gounden and Dr 
Ravindra Sirkar , consultant chemical pathologists at the Department of Chemical Pathology 
UKZN. 
  
XLIV 
 
Appendix 2: The Guidelines for Authorship for the Journal selected for submission of 
the manuscript 
 
Include the author guidelines in order that the examiner can assess adherence to the journal 
requirements. 
  
 
ISSN 0256-9574 printed version 
ISSN 2078-5135 online version  
INSTRUCTIONS TO AUTHORS 
 Scope and policies 
 Conflict of interest 
 Manuscripts preparation 
 Manuscripts submission 
  
Scope and policies 
 
The SAMJ is a monthly, peer–reviewed, internationally indexed, 
general medical journal publishing leading research impacting 
clinical care in Africa. The Journal is not limited to articles that 
have ‘general medical content’, but is intending to capture the 
spectrum of medical and health sciences, grouped by relevance 
to the country’s burden of disease. This will include research in 
the social sciences and economics that is relevant to the 
medical issues around our burden of disease. 
The journal carries research articles and letters, editorials, 
clinical practice and other medical articles and personal 
opinion, South African health–related news, obituaries, general 
correspondence, and classified advertisements (refer to the 
section policies for further information). 
 
  
Conflict of interest 
 
Conflicts of interest can derive from any kind of relationship or 
association that may influence authors’ or reviewers’ opinions 
about the subject matter of a paper. The existence of a conflict 
– whether actual, perceived or potential – does not preclude 
publication of an article. However, we aim to ensure that, in 
such cases, readers have all the information they need to 
enable them to make an informed assessment about a 
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publication’s message and conclusions. We require that both 
authors and reviewers declare all sources of support for their 
research, any personal or financial relationships (including 
honoraria, speaking fees, gifts received, etc) with relevant 
individuals or organisations connected to the topic of the 
paper, and any association with a product or subject that may 
constitute a real, perceived or potential conflict of interest. If 
you are unsure whether a specific relationship constitutes a 
conflict, please contact the editorial team for advice. If a 
conflict remains undisclosed and is later brought to the 
attention of the editorial team, it will be considered a serious 
issue prompting an investigation with the possibility of 
retraction. 
  
Manuscripts preparation 
 
Preparing an article for anonymous review 
 
To ensure a fair and unbiased review process, all submissions 
are to include an anonymised version of the manuscript. The 
exceptions to this are Correspondence, Book reviews and 
Obituary submissions. 
Submitting a manuscript that needs additional blinding can 
slow down your review process, so please be sure to follow 
these simple guidelines as much as possible:  
 An anonymous version should not contain any author, 
affiliation or particular institutional details that will 
enable identification. 
 Please remove title page, acknowledgements, contact 
details, funding grants to a named person, and any 
running headers of author names. 
 Mask self–citations by referring to your own work in 
third person. 
General article format/layout 
 
Accepted manuscripts that are not in the correct format 
specified in these guidelines will be returned to the author(s) 
for correction, which will delay publication. 
General:  
 Manuscripts must be written in UK English. 
 The manuscript must be in Microsoft Word or RTF 
document format. Text must be single–spaced, in 12–
point Times New Roman font, and contain no 
unnecessary formatting (such as text in boxes). 
  
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 Please make your article concise, even if it is below the 
word limit. 
 Qualifications, full affiliation (department, 
school/faculty, institution, city, country) and contact 
details of ALL authors must be provided in the 
manuscript and in the online submission process. 
 Abbreviations should be spelt out when first used and 
thereafter used consistently, e.g. 'intravenous (IV)' or 
'Department of Health (DoH)'. 
 Scientific measurements must be expressed in SI units 
except: blood pressure (mmHg) and haemoglobin 
(g/dL). 
 Litres is denoted with an uppercase L e.g. 'mL' for 
millilitres). 
 Units should be preceded by a space (except for % and 
°C), e.g. '40 kg' and '20 cm' but '50%' and '19°C'. 
 Please be sure to insert proper symbols e.g. π not u for 
micro, a not a for alpha, b not B for beta, etc. 
 Numbers should be written as grouped per thousand–
units, i.e. 4 000, 22 160. 
 Quotes should be placed in single quotation marks: i.e. 
The respondent stated: '...' 
 Round brackets (parentheses) should be used, as 
opposed to square brackets, which are reserved for 
denoting concentrations or insertions in direct quotes. 
 If you wish material to be in a box, simply indicate this 
in the text. You may use the table format – this is the 
only exception. Please DO NOT use fill, format lines and 
so on. 
SAMJ is a generalist medical journal, therefore for articles 
covering genetics, it is the responsibility of authors to apply the 
following:  
 Please ensure that all genes are in italics, and 
proteins/enzymes/hormones are not. 
 Ensure that all genes are presented in the correct case 
e.g. TP53 not Tp53. 
**NB: Copyeditors cannot be expected to pick up and 
correct errors wrt the above, although they will raise 
queries where concerned. 
 Define all genes, proteins and related shorthand terms 
at first mention, e.g. ‘188del11’ can be glossed as ‘an 
11 bp deletion at nucleotide 188.’ 
 Use the latest approved gene or protein symbol as 
appropriate: 
o Human Gene Mapping Workshop (HGMW): 
genetic notations and symbols 
o HUGO Gene Nomenclature Committee: approved 
gene symbols and nomenclature 
o OMIM: Online Mendelian Inheritance in Man 
(MIM) nomenclature and instructions 
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o Bennet et al. Standardized human pedigree 
nomenclature: Update and assessment of the 
recommendations of the National Society of 
Genetic Counselors. J Genet Counsel 
2008;17:424–433: standard human pedigree 
nomenclature. 
Illustrations/photos/scans  
 If illustrations submitted have been published 
elsewhere, the author(s) should provide consent to 
republication obtained from the copyright holder. 
 Figures must be numbered in Arabic numerals and 
referred to in the text e.g. '(Fig. 1)'. 
 Each figure must have a caption/legend: Fig. 1. 
Description (any abbreviations in full). 
 All images must be of high enough resolution/quality for 
print. 
 All illustrations (graphs, diagrams, charts, etc.) must be 
in PDF form. 
 Ensure all graph axes are labelled appropriately, with a 
heading/description and units (as necessary) indicated. 
Do not include decimal places if not necessary e.g. 0; 
1.0; 2.0; 3.0; 4.0 etc. 
 Scans/photos showing a specific feature e.g. 
Intermediate magnification micrograph of a low 
malignant potential (LMP) mucinous ovarian tumour. 
(H&E stain). –include an arrow to show the tumour. 
 Each image must be attached individually as a 
'supplementary file' upon submission (not solely 
embedded in the accompanying manuscript) and named 
Fig. 1, Fig. 2, etc. 
Tables  
 Tables should be constructed carefully and simply for 
intelligible data representation. Unnecessarily 
complicated tables are strongly discouraged. 
 Large tables will generally not be accepted for 
publication in their entirety. Please consider shortening 
and using the text to highlight specific important 
sections, or offer a large table as an addendum to the 
publication, but available in full on request from the 
author. 
 Embed/include each table in the manuscript Word file – 
do not provide separately as supplementary files. 
 Number each table in Arabic numerals (Table 1, Table 2, 
etc.) and refer to consecutively in the text. 
 Tables must be cell–based (i.e. not constructed with 
text boxes or tabs) and editable. 
 Ensure each table has a concise title and column 
headings, and include units where necessary. 
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 Footnotes must be indicated with consecutive use of the 
following symbols: * † ‡ § ¶ || then ** †† ‡‡ etc. 
 
o Do not: Use [Enter] within a row to make ‘new 
rows’: 
 
o Rather: 
Each row of data must have its own proper row: 
 
o Do not: use separate columns for n and %: 
 
o Rather: 
Combine into one column, n (%): 
 
o Do not: have overlapping categories, e.g.: 
 
o Rather: 
Use <> symbols or numbers that don’t overlap: 
References 
 
NB: Only complete, correctly formatted reference lists in 
Vancouver style will be accepted. Reference lists must be 
generated manually and not with the use of reference manager 
software. Endnotes must not be used.  
 Authors must verify references from original sources. 
 Citations should be inserted in the text as superscript 
numbers between square brackets, e.g. These 
regulations are endorsed by the World Health 
Organization,[2] and others.[3,4–6] 
 All references should be listed at the end of the article 
in numerical order of appearance in the Vancouver style 
(not alphabetical order). 
 Approved abbreviations of journal titles must be used; 
see the List of Journals in Index Medicus. 
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 Names and initials of all authors should be given; if 
there are more than six authors, the first three names 
should be given followed by et al. 
 Volume and issue numbers should be given. 
 First and last page, in full, should be given e.g.: 1215–
1217 not 1215–17. 
 Wherever possible, references must be accompanied by 
a digital object identifier (DOI) link). 
Authors are encouraged to use the DOI lookup service 
offered by CrossRef: 
o On the Crossref homepage, paste the article title 
into the ‘Metadata search’ box. 
o Look for the correct, matching article in the list 
of results. 
o Click Actions > Cite 
o Alongside 'url =' copy the URL between { }. 
o Provide as follows, e.g.: 
https://doi.org/10.7196/07294.937.98x 
Some examples: 
 Journal references: Price NC, Jacobs NN, Roberts DA, et 
al. Importance of asking about glaucoma. Stat Med 
1998;289(1):350-355. 
http://dx.doi.org/10.1000/hgjr.182 
 Book references: Jeffcoate N. Principles of Gynaecology. 
4th ed. London: Butterworth, 1975:96–101. 
 Chapter/section in a book: Weinstein L, Swartz MN. 
Pathogenic Properties of Invading Microorganisms. In: 
Sodeman WA, Sodeman WA, eds. Pathologic 
Physiology: Mechanisms of Disease. Philadelphia: WB 
Saunders, 1974:457–472. 
 Internet references: World Health Organization. The 
World Health Report 2002 – Reducing Risks, Promoting 
Healthy Life. Geneva: WHO, 2002. 
http://www.who.int/whr/2002 (accessed 16 January 
2010). 
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o Government Gazettes: 
National Department of Health, South Africa. 
National Policy for Health Act, 1990 (Act No. 116 
of 1990). Free primary health care services. 
Government Gazette No. 17507:1514. 1996. 
In this example, 17507 is the Gazette Number. 
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This is followed by :1514 – this is the notice 
number in this Gazette. 
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Notice R176). 
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Rex v Jopp and Another: Name of the parties 
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(4): Volume number 
SA: SA Law Reports 
11: Page or section number 
(N): In this case Natal – where the case was 
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heard. Similarly, (C) woud indicate Cape, (G) 
Gauteng, and so on. 
NOTE: no . after the v 
 
 Other references (e.g. reports) should follow the same 
format: Author(s). Title. Publisher place: Publisher 
name, year; pages. 
 Cited manuscripts that have been accepted but not yet 
published can be included as references followed by '(in 
press)'. 
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in the text must not appear in the reference list. The 
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Appendix 3: Ethical approvals 
 
Included hospital and provincial approvals as well as the BREC approval (or waiver if appropriate). 
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Appendix 4: Data collection tools (for example) 
 
Not applicable  
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Appendix 5: Raw data 
 
DOA Patient unique numberPatie t file number Twin Age raw Age ( months) 
14/07/2013 2 15152/13 28days 0.93
01/10/2014 206 65542/14 1month7days 1.23
No file 7033 2173/15 1yr17days 12.57
No file 7037 24320/15 3mnths15days 3.50
13/11/2015 7058 2641/15 twin 1 3mnths23days 3.77
13/11/2015 7475 2642/15 twin 2 3mnths23days 3.77
16/08/2016 7487 18951/16 2mnth23days 2.77
16/09/2014 7498 7396/14 1yr2mnths17days 14.57
No file 7505 71378/15 1yr11mnths15days 23.50
27/05/2015 7515 12548/15 1yr0months0days 12.00
Not documented 7516 27773/15 3mnths17days 3.57
7533 2208/16 7yrs6mnths16days 90.53
7536 4242/14 9yrs12days 108.40
7538 10556/15 9yrs7days 108.63
7541 6973/15 9yrs10mnths26days 118.87
22/12/2015 7559 29617/15 11yrs2days 132.07
15 50191 No age
31/10/2014 16 513771 2days 0.07
02/11/2014 17 513817 10days 0.33
19 600687 4days 0.13
21 515211 2months5days 2.17
22 600648 2mnths12days 2.40
23 603462 7days 0.23
24 603704 12 days 0.40
26 603686 3 days 0.10
27 603443 13 days 0.43
28 604495 20 days 0.67
06/05/2015 29 604589 24 days 0.80
30 605380 11days 0.37
31 605854 No age 0.03
Not documented 32 605852 5days 0.17
37 606457 1mnth14days 1.47
02/06/2015 38 606267 21 days 0.70
39 60694 4 days 0.13
Not documented 40 606327 9 days 0.30
42 606144 27days 0.90
44 607158 6days 0.20
45 605672 1mnth8days 1.27
46 606406 9days 0.30
Not documented 48 607336 9 days 0.30
49 607569 9 days 0.30
50 606941 1day 0.03
53 610479 1day 0.03
54 610339 6days 0.20
55 612371 6days 0.20
56 612741 2days 0.07
61 613527 1mnth15days 1.50
62 70199 6days 0.20
12/01/2016 63 700286 16days 0.53
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Gender  ( M/F) Clinical picture   (  meningitis/ premature) Clin catergorisation Fever(Y/N) Ward PCT PCT catergorisation
M No meningism,ex prem 0 Y PRU >0.5 1
F No meningism 0 Y PRU <0.5 0
M No history 2 Med ward <0.5 0
F No history 2 PRU <0.5 0
M Bulg fontanelle, incr tone, LBW 1 N Med ward <0.5 0
M Bulg fontanelle, incr tone, brisk ref, LBW 1 Y Med ward <0.5 0
F No meningism, fever present 1 Y PRU >10 3
M Irritable with meningism 1 Y Med ward<0 <0.5 0
M No history 2 PRU >0.5 1
M No features of meningitis 0 Y Med ward <0.5 0
F No features of meningitis 0 Y PRU >0.5 1
F No history 2 Med ward >0.5 1
M No history 2 Med ward <0.5 0
M No history 2 PRU >10 3
F No history 2 PRU >10 3
M No meningism 0 Y PRU <0.5 0
M No history 2 Nursey >10 3
F No meningism 0 N Nursey >10 3
M No meningism 0 N Nursey >10 3
M No history 2 Nursey <0.5 0
F No history 2 Nursey >2 2
F No history 2 Nursey <0.5 0
M No history 2 Nursey >0.5 1
M No history 2 Nursey >10 3
M No history 2 Nursey >10 3
F No meningism 0 N Nursey <0.5 0
M No meningism 0 N Nursey <0.5 0
M No meningism 0 N Nursey <0.5 0
F No meningism 0 N Nursey >10 3
M No meningism 0 N Nursey >2 2
F No history 2 Nursey <0.5 0
F No history 0 Nursey <0.5 0
F Jittery 1 N ICU <0.5 0
M No history 2 Nursey >0.5 1
M No history 2 Nursey >0.5 1
F No meningism 0 Y Nursey <0.5 0
M No history 2 Nursey >10 3
M No meningism 0 N Nursey <0.5 0
M No history 2 Nursey >10 3
M No history 2 Nursey >0.5 1
M No history 2 Nursey >10 3
M No history 2 Nursey >0.5 1
F Decr tone 1 N Nursey >0.5 1
F Fisting, incr tone 1 N Nursey >0.5 1
M No history 2 Nursey >0.5 1
M No history 2 Nursey <0.5 0
F No history 2 Nursey >2 2
M Abnormal neurology 1 N Nursey <0.5 0
F No menigism 0 Y Nursey >0.5 1
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CRP mg/L WCC CSF TP CSF TP CSF glu CSFcl CSF micro CSF Culture pos /neg ( number CSF Culture categorisation
27 15.43 0poly, 4lymph,260erythro and xantho trace Negative 1
13 10.05 Not done 0
135 8.3 Not done 0
28 No result 0.62 High 3.2 118 10Poly,4lymph Positive 2
8 14.19 1.57 High 2.6 120 1+neutroph, 1+lymph Negative 1
15 12.58 0.13 Low 3.2 117 0poly,0lymph Negative 1
39 10 Not done 0
152 19.6 Positive 2
89 2.8 0.14 low 3.4 115 2poly Negative 1
33 13.35 Not done 0
31 7.7 Not done 0
188 10.3 Not done 0
133 1.84 Not done 0
323 18.6 Not done 0
320 No result 0.27 normal 2.7 122 no cells Negative 1
9 18.08 Not done 0
11 clotted Not done 0
12 8.67 1.81 High 4.9 121 8poly, 32 lymph,>1000erythrocytes Negative 1
58 3.26 0.79 Normal 6.4 125 0poly, 2lymph Negative 1
75 17.14 Not done 0
166 19.71 Not done 0
18 25.43 Not done 0
0unsuitable Not done 0
9 24.4 Not done 0
125 15.54 Not done 0
8 6.59 Not done 0
17 2.35 Not done 0
25 14.84 scanty poly&lymph Negative 1
28 14.25 1.88 High 4.5 123 Negative 1
31 7.06 Not done 0
7 3.74 0.92 High 2.7 110 0 neutr, 0lymph Positive 2
6 8.5 Not done 0
165 13.35 0.59 Normal 6.5 109 0poly,0lymph Negative 1
7 no result Not done 0
5 7.22 Not done 0
14 10.18 0.83 High 5.8 114 0 cells Negative 1
54 17.19 Not done 0
40 14.6 Not done 0
175 clotted Not done 0
130 15.22 2.42 High 8.5 109 Positive 2
72 insuff 0.59 Normal 4.4 122 0 cells Negative 1
27 25.56 Not done 0
6 22.36 1.14 High 10 119 scanty leucocytes Negative 1
67 7.17 Not done 0
29 26.3 Not done 0
16 7 Not done 0
160 11.91 1.5 High 5 118 0poly,0lymph Negative 1
6 21.5 Negative 1
7 16.5 1.48 High 1.6 120 clotted Negative 1
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No bacteria seen Negative 1 Amikacin, tazocin, cefotaxime
Not done 0 No antibiotics
Positive 2 Staph aureus Not known
Staph Aureus(?contamination)Positive 2 Stap aureus Not known
Positive 2 Staph species(?contam)Augmentin,genta,erythromycin,imipenem
Positive 2 Gram positive cocci(?contam)Aug entin,genta,erythromycin
Positive 2 Gram positive cocci(?contam)Tazocin, amikacin
Cryptococcus
No  culture Negative 1 No growth
Positive 2 Staph aureus
Positive 2 Staph aureus
Negative 1 No growth
Negative 1 No growth
Not done 0 Not documented
No growth Not documented
Negative 1 No growth
Not done 0
No growth
No growth
Positive 2 gram positive cocci and bacilli(?contam)
Positive 2 Gram pos bacilli (?contam)
Negative 1 No growth
Positive 2 Staph species(?contam)
Positive 2 Gram positive cocci in clusters
Negative 1 No growth
Positive 2 Stah epidermidis(?contam)
Positive 2 Staph species(?contam)
No growth
Antibiotics-Genta, ampicillin, vanco,imipenem
Klebsiella pn
Not done 0
Not done 0
No growth Negative 1 No growth
Positive 2 Klebsiella pneumonia
Positive 2 Klebsiella&Staph
Not done 0
Acinebacter
No growth
Positive 2 Gram neg bacilli(Acinetobacter
No growth
Positive Gram neg bacilli, acibacter
Negative 1
Positive 2 Staph species(?contamination)
No growth
No growth
No bacteria
